Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease
January 09, 2023 07:00 ET
|
Autolus Therapeutics plc
LONDON, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces...
CABA FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important April 29 Deadline in Securities Class Action – CABA
April 29, 2022 13:10 ET
|
The Rosen Law Firm PA
NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or...
CABA FINAL DEADLINE TODAY: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important April 29 Deadline in Securities Class Action – CABA
April 29, 2022 11:11 ET
|
The Rosen Law Firm PA
NEW YORK, April 29, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant...
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important April 29 Deadline in Securities Class Action – CABA
April 24, 2022 17:00 ET
|
The Rosen Law Firm PA
NEW YORK, April 24, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or...
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important April 29 Deadline in Securities Class Action – CABA
April 19, 2022 17:15 ET
|
The Rosen Law Firm PA
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or...
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CABA
April 12, 2022 18:00 ET
|
The Rosen Law Firm PA
NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – CABA
April 06, 2022 11:13 ET
|
The Rosen Law Firm PA
NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or...
ROSEN, A LEADING LAW FIRM, Encourages Cabaletta Bio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CABA
March 23, 2022 16:00 ET
|
The Rosen Law Firm PA
NEW YORK, March 23, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or...
NASDAQ: CABA Investor Alert: April 29th Deadline in Lawsuit for Investors in Cabaletta Bio, Inc. (NASDAQ: CABA) shares announced by Shareholders Foundation
March 22, 2022 07:05 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, March 22, 2022 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in Cabaletta Bio, Inc. (NASDAQ: CABA) shares.Investors who...
CABA NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CABA
March 17, 2022 20:30 ET
|
The Rosen Law Firm PA
NEW YORK, March 17, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant...